Changes

no edit summary
Line 559: Line 559:  
|
 
|
 
|-
 
|-
|Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma||Disease|| ||SP
+
|Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma||Disease||Honey Reddi
 +
|SP
 
|
 
|
 
|
 
|
 
|
 
|
 
|-
 
|-
|       Monoclonal B-cell  Lymphocytosis||Disease|| ||SP
+
|       Monoclonal B-cell  Lymphocytosis||Disease||Honey Reddi
 +
|SP
 
|
 
|
 
|
 
|
 
|
 
|
 
|-
 
|-
|B-cell Prolymphocytic Leukemia||Disease|| ||SP
+
|B-cell Prolymphocytic Leukemia||Disease||Honey Reddi
 +
|SP
 
|
 
|
 
|
 
|
Line 604: Line 607:  
|Jennelle Hodge to review
 
|Jennelle Hodge to review
 
|-
 
|-
|Lymphoplasmacytic Lymphoma||Disease|| ||SP
+
|Lymphoplasmacytic Lymphoma||Disease||Honey Reddi
 +
|SP
 
|
 
|
 
|
 
|
 
|
 
|
 
|-
 
|-
|   Waldenstrom  Macroglobulinemia||Disease|| ||SP
+
|   Waldenstrom  Macroglobulinemia||Disease||Honey Reddi
 +
|SP
 
|
 
|
 
|
 
|
Line 639: Line 644:  
|
 
|
 
|-
 
|-
|Plasma Cell Neoplasms||'''''Overview'''''|| ||SP
+
|Plasma Cell Neoplasms||'''''Overview'''''||Zhenya Tang
 +
|SP
 
|
 
|
 
|
 
|
 
|
 
|
 
|-
 
|-
|   Non-IgM Monoclonal  Gammopathy of Undetermined Significance||Disease|| ||SP
+
|   Non-IgM Monoclonal  Gammopathy of Undetermined Significance||Disease||Zhenya Tang
 +
|SP
 
|
 
|
 
|
 
|
 
|
 
|
 
|-
 
|-
|    Plasma Cell Myeloma||Disease|| ||SP
+
|    Plasma Cell Myeloma||Disease||Zhenya Tang
 +
|SP
 
|
 
|
 
|
 
|
 
|
 
|
 
|-
 
|-
|    Plasma Cell Myeloma  Variants||Disease|| ||SP
+
|    Plasma Cell Myeloma  Variants||Disease||Zhenya Tang
 +
|SP
 
|
 
|
 
|
 
|
 
|
 
|
 
|-
 
|-
|    Plasmacytoma||Disease|| ||SP
+
|    Plasmacytoma||Disease||Zhenya Tang
 +
|SP
 
|
 
|
 
|
 
|
Line 694: Line 704:  
|
 
|
 
|-
 
|-
|Extranodal Marginal Zone Lymphoma of Mucosa-Associated Lymphoid  Tissue (MALT Lymphoma)||Disease|| ||SP
+
|Extranodal Marginal Zone Lymphoma of Mucosa-Associated Lymphoid  Tissue (MALT Lymphoma)||Disease||Zhenya Tang & Trainee
 +
|SP
 
|
 
|
 
|
 
|
Line 744: Line 755:  
|
 
|
 
|-
 
|-
|Mantle Cell Lymphoma||Disease|| ||SP
+
|Mantle Cell Lymphoma||Disease||Mahsa Khanlari
 +
|SP
 
|
 
|
 
|
 
|
 
|
 
|
 
|-
 
|-
|    Leukemic Non-Nodal  Mantle Cell Lymphoma||Disease|| ||SP
+
|    Leukemic Non-Nodal  Mantle Cell Lymphoma||Disease||Mahsa Khanlari
 +
|SP
 
|
 
|
 
|
 
|
 
|
 
|
 
|-
 
|-
|    In Situ Mantle Cell  Neoplasia||Disease|| ||SP
+
|    In Situ Mantle Cell  Neoplasia||Disease||Mahsa Khanlari
 +
|SP
 
|
 
|
 
|
 
|
Line 1,059: Line 1,073:  
|
 
|
 
|-
 
|-
|Anaplastic Large Cell Lymphoma, ALK-Positive||Disease|| ||SP
+
|Anaplastic Large Cell Lymphoma, ALK-Positive||Disease||Mahsa Khanlari
 +
|SP
 
|
 
|
 
|
 
|
 
|
 
|
 
|-
 
|-
|Anaplastic Large Cell Lymphoma, ALK-Negative||Disease|| ||SP
+
|Anaplastic Large Cell Lymphoma, ALK-Negative||Disease||Mahsa Khanlari
 +
|SP
 
|
 
|
 
|
 
|